Immuron (IMRN) Share-based Compensation (IS) (2017 - 2023)

Immuron (IMRN) recorded quarterly Share-based Compensation (IS) of $2.0 million in Q3 2023, up 1249.86% quarter-over-quarter from $151687.1 in Q2 2023.

Immuron (IMRN) Share-based Compensation (IS) (2017 - 2023) Analysis & Trends

Immuron's Share-based Compensation (IS) history runs 6 years deep, the most recent figure standing at $2.0 million for Q3 2023.

  • In Q3 2023, Share-based Compensation (IS) changed N/A year-over-year to $2.0 million; the TTM figure through Sep 2023 stood at $2.0 million (changed N/A YoY), while the FY2023 annual figure was $2.0 million, changed N/A from the prior year.
  • Share-based Compensation (IS) was $2.0 million for Q3 2023 at Immuron, up from $151687.1 in the prior quarter.
  • In the past five years, Share-based Compensation (IS) ranged from a high of $2.0 million in Q3 2023 to a low of -$42.9 billion in Q4 2021.
  • Historically, Share-based Compensation (IS) has averaged -$5.4 billion across 5 years, with a median of $109827.2 in 2023.
  • The sharpest annual moves came in 2021 and 2023: Share-based Compensation (IS) tumbled 202666646.42% in 2021, then surged 123.18% in 2023.
  • A 5-year view of Share-based Compensation (IS) shows it stood at $6070.0 in 2019, then slumped by 448.6% to -$21160.1 in 2020, then plunged by 202666646.42% to -$42.9 billion in 2021, then surged by 100.0% to $2.0 million in 2022, then advanced by 2.07% to $2.0 million in 2023.
  • The last three Share-based Compensation (IS) figures came in at $2.0 million (Q3 2023), $151687.1 (Q2 2023), and $2.0 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (IS) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.45 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 892,057.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 14.90 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Immuron 921.61 Mn 921.58 Mn - -

Historic Data

Download Data
DateValue
Sep 28, 2023 2.05 Mn
Sep 28, 2023 2.05 Mn
Jun 30, 2023 151,687.08
Jun 30, 2023 151,687.08
Dec 31, 2022 2.01 Mn
Dec 31, 2022 2.01 Mn
Jun 30, 2022 67,967.42
Jun 30, 2022 67,967.42
Dec 31, 2021 -42.88 Bn
Dec 31, 2021 -42.88 Bn
Jun 30, 2021 1.63 Mn
Jun 30, 2021 1.63 Mn
Dec 31, 2020 -21,160.13
Dec 31, 2020 -21,160.13
Dec 31, 2019 6,070.00
Dec 31, 2019 6,070.00
Dec 31, 2017 -46,380.23
Dec 31, 2017 -46,380.23